Navigation Links
InVitria Among Leading Innovators in Cell Culture Media According to Top Biotechnology Publication
Date:1/22/2009

The Company's groundbreaking products are featured in Genetic Engineering News for delivering the promise of safety without sacrificing productivity and performance.

Fort Collins, CO (PRWEB) January 22, 2009 -- InVitria's product line was featured in the Jan. 15, 2009 edition of Genetic Engineering News (GEN, Jan 15, 2009 pp 32-34). The article, entitled Culture Media Underlies Productivity Gains, referenced the productivity and safety improvements achieved through cell culture media optimization. New media components, such as InVitria's animal free recombinant media, have contributed to these improvements.

Test results have confirmed that InVitria's recombinant albumin (Cellastim™) outperforms plasma-derived human serum albumin and results in productivity improvements in CHO and hybridoma cell lines.

InVitria's recombinant lactoferrin (Lacromin™) is a strong cell growth factor and is capable of performing better in cell culture media than insulin and insulin-like growth factors. Research has shown Lacromin™ to be a major advance in promoting cell growth and productivity across a variety of cell lines.

Also mentioned in the article is InVitria's Lysobac™, a cell lysis reagent used in microbial fermentation to improve recombinant protein yield and deliver consistent quality, as well as the safety of an animal free reagent. Lysobac™ is many times more active than chicken lysozyme.

InVitria's performance enhancing recombinants offer producers affordable, well-defined and regulatory compliant cell culture media and bacterial lysis components. They can also contribute to operational efficiency and reduced capital costs.

"InVitria is committed to improving our customers' cell culture and bacterial fermentation performance by producing safe, consistent and affordable components," said Scott Deeter, President of InVitria. "We have been greatly encouraged by the results InVitria customers have achieved using our products. We hope to build upon these successes and share with the bioprocessing, diagnostic and stem cell and regenerative medicine communities the power of InVitria's products."

About InVitria
InVitria manufactures and sells animal free components for cell culture media and bacterial lysis. InVitria's affordable products can enhance cell growth, reduce doubling times and optimize performance for the bioprocessing, stem cell and regenerative medicine, life science and diagnostics markets.

Learn more about InVitria's products at InVitria

Contact InVitria's product customer service specialists by e-mail or phone.

Phone: 1-800-916-8311

# # #

Read the full story at http://www.prweb.com/releases/genengnews/invitria/prweb1898894.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
2. InVitrias Cellastim Delivers Superior Results in Mammalian Cell Culture
3. InVitria Touts Product Advantages at Cambridges Cell Culture Conference
4. InVitria Sponsors Cambridge Healthtechs Optimizing Cell Culture Development Conference
5. InVitria Further Strengthens Sales Team with Promotion of Brandy Sargent to Account Manager - Western United States
6. InVitria Expands Sales Team
7. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
8. Growing Interest in DNA-Based Genetic Testing Among African American with Historic Election of President Elect Barack Obama
9. Former NASDAQ International President Among Execs Launching Firm to Access Global Markets
10. According to AlphaDetail, Inc. Merck and Tibotec Therapeutics Lead Among Infectious Disease Specialists
11. Use of Biologic Agents Continues to Expand Among US Rheumatologists - Can New Agents Shift the Treatment Paradigm in Rheumatoid Arthritis?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... At its national ... Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based ... selected for membership in ARCS Alumni Hall of Fame . ASTER Labs ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is ... and 8th June 2018 in San Francisco, CA. The Summit brings together current and ... distinguished CEOs, board directors and government officials from around the world to address key ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... , April 6, 2017 ... RFID, ANPR, Document Readers, by End-Use (Transportation & Logistics, ... Facility, Oil, Gas & Fossil Generation Facility, Nuclear Power), ... Educational, Other) Are you looking for a ... sector? ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
Breaking Biology News(10 mins):